首頁 › 非小細胞肺癌 › 紐約州 › New Rochelle
New Rochelle, NY 的 非小細胞肺癌 臨床試驗
18 項針對 非小細胞肺癌 的研究正在 New Rochelle（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- The Cancer Institute at Saint Francis Hospital, East Hills · 距離 11 英里
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
招募中2 期
- Memorial Sloan Kettering Westchester, Harrison · 距離 5 英里
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
招募中1 期
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 距離 5 英里
Using Urine Samples to Identify Lung Cancer
招募中觀察性研究歡迎健康志工
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 距離 5 英里
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
招募中2 期
- Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison · 距離 5 英里
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
招募中
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 距離 5 英里
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
招募中3 期
- Memorial Sloan Kettering Westchester, Harrison · 距離 5 英里
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
招募中2 期
- Memorial Sloan Kettering Westchester, Harrison · 距離 5 英里
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
招募中1/2 期
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 距離 5 英里
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer
招募中觀察性研究
- Memorial Sloan Kettering Westchester (Consent Only), Harrison · 距離 5 英里
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
招募中1/2 期
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 距離 5 英里
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
招募中2 期
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 距離 5 英里
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Memorial Sloan Kettering Westchester, Harrison · 距離 5 英里
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
招募中1/2 期
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 距離 5 英里
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
招募中2 期
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 距離 5 英里
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
招募中2 期
- Memorial Sloan Kettering Westchester, Harrison · 距離 5 英里
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
招募中2 期
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 距離 5 英里
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Manhasset · 距離 9 英里
其他城市的 非小細胞肺癌 試驗
- Houston, TX145 項研究
- New York City, NY121 項研究
- Arlington, VA104 項研究
- Nashville, TN97 項研究
- Boston, MA90 項研究
- Los Angeles, CA87 項研究
- St. Louis, MO73 項研究
- Chicago, IL61 項研究
- Baltimore, MD60 項研究
- San Antonio, TX59 項研究
- Columbus, OH57 項研究
- Washington, DC55 項研究
New Rochelle 的其他研究
- 乳癌38 項研究
- 前列腺癌16 項研究
- 多發性骨髓瘤14 項研究
- 急性髓系白血病13 項研究
- 膀胱癌11 項研究
- 肺癌11 項研究
- 子宮內膜癌11 項研究
- 轉移性癌症10 項研究
- 癌症（所有類型）10 項研究
- 卵巢癌9 項研究
- 心血管疾病8 項研究
- 胰臟癌8 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。